Friday, Jan 25, 2019 News Recap: Using Telemedicine HCV Care Model in Prisons in SPAIN “HCV telemedicine program satisfying, cost-effective in Spanish prison: A telemedicine program brought high levels of satisfaction and proved cost effective in patients with hepatitis C in a Spanish prison, according to data presented at The Liver Meeting 2018…” Read more about Spain’s prison-based HCV “Telemedicine” treatment model. Saturday in Surrey! Visit HepC
HepCBC is quite interested in NASH because people with hepatitis C are particularly vulnerable to NASH, even after being cured of hepatitis C! (Reference for relation between post-SVR HCV and NASH: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5859229/) Register for free CCO webinar: “Identifying and Managing NASH [Non-alcoholic steatohepatitis] in High-Risk Populations: A Silent Epidemic, NASH affects 30 million Americans, or 12% of all adults. By 202
Fatty liver is among the most frequent causes of liver disease in Canada and in Western countries and is one of the main indications for liver transplant. For some time, researchers have suspected that people living with HIV could be at higher risk of developing liver disease, which, as a result of longer life expectancy thanks to antiretroviral therapy, has become the major cause of their mortality in North America. Due to the invasiveness of liver biops
Friday, November 4, 2017 News Recap: Access to Treatment Hepatitis C could be eliminated in Canada, but drug prices, screening barriers stand in the way – Most of the 70 million patients infected with hepatitis C worldwide could be cured for $50 US each Many countries — including Canada — have committed to a global goal of eliminating hepatitis C by 2030. But new data released at the summit in Brazil shows that only nine countries are on track to me...
The study showed that even after achieving a cure for hepatitis C, approximately 50% of those patients demonstrated evidence of NAFLD. WASHINGTON, DC — Evidence of steatosis is found in almost half the patients with hepatitis C who achieved a sustained virologic response after treatment with direct-acting antivirals, results from a prospective study show. "Fatty liver is very common now that hepatitis C is being treated effectively," said Mazen Nouredd